September 11, 2007
A material developed at Virginia Commonwealth University to stop heaving bleeding in wounded soldiers has been given the green light from the FDA.
The FDA has approved WoundStat for use on humans and commercial
sale. When the material is applied with pressure to a hemorrhaging wound, the material forms a seal to stop rapid blood loss. Tests show the substance stopped lethal hemorrhaging within two minutes.
Bethesda, Maryland-based TraumaCure plans to start offering WoundStat to U.S. military forces by late fall, followed by first responders such as firefighters and emergency medical technicians.
The comments sections of Newsplex.com are designed for thoughtful, intelligent conversation and debate. We want to hear from our viewers, but we only ask that you use your best judgment. E-mail is required, but will not be displayed with comment.
As a host Newsplex.com welcomes a wide spectrum of opinions. However this is a site that we host. We have a responsibility to all our readers to try to keep our comment section fair and decent. For that reason The Newsplex reserves the right to not post or to remove any comment.
If you have any ideas to improve the conversation or this section let us know. Send an e-mail to firstname.lastname@example.org.
powered by Disqus